Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biocatalytic Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109628504A details a biphasic microbial resolution method. This technology enhances purity and yield for pharmaceutical intermediates while offering supply chain cost advantages.
Patent CN1597970A details microbial resolution for high-purity chiral intermediates. Offers cost-effective supply chain solutions for pharma and liquid crystal manufacturing.
Patent CN1644012A reveals enzymatic resolution for diltiazem precursor. Offers high optical purity and scalable manufacturing for reliable pharmaceutical intermediate supply chains.
Patent CN101302543A reveals a microbial method for high-purity (S)-phenylethylene glycol. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN109504634A reveals enzymatic resolution for high-purity agrochemical intermediates. Achieve superior enantiomeric excess with reduced environmental impact and scalable production.
Advanced biocatalytic dynamic kinetic resolution patent CN103820521B enables high-purity pharmaceutical intermediate manufacturing with substantial cost reduction and supply reliability.
Novel enzymatic resolution process ensures high purity and cost efficiency for pharmaceutical intermediate manufacturing supply chains globally. This patent offers significant advantages.
Patent CN104558033B reveals biocatalytic resolution for high-purity L-glufosinate-ammonium. Significant cost reduction and supply chain reliability for agrochemical intermediates.
Novel biocatalytic resolution method for high-purity dextro-cis-chrysanthemic acid. Simplifies production, reduces costs, and ensures supply chain stability for pyrethroid manufacturers.
Patent CN104745509B reveals a novel strain for producing optical pure agrochemical intermediates. Offers high ee value and scalable biocatalysis for cost reduction.
Patent CN106119224B reveals high-efficiency esterase for chiral synthesis. Offers mild conditions and supply chain stability for pharma intermediates.
Patent CN112301064A reveals a biocatalytic route for high-purity DV acid. This method simplifies purification and ensures reliable agrochemical intermediate supply.
Patent CN118086121A reveals efficient biocatalytic route for R-Metalaxyl intermediate. Enhances purity and supply chain stability for global agrochemical manufacturers.
Patent CN1115343C details a novel enzymatic route for chiral cyclopentene amines, offering cost-effective API intermediate manufacturing with high enantiomeric purity.